Literature DB >> 10933672

In vitro antifungal susceptibility of Alternaria spp. and Ulocladium spp.

I Pujol, C Aguilar, J Gené, J Guarro.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933672     DOI: 10.1093/jac/46.2.337

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Activation of Melanin Synthesis in Alternaria infectoria by Antifungal Drugs.

Authors:  Chantal Fernandes; Rafael Prados-Rosales; Branca M A Silva; Antonio Nakouzi-Naranjo; Mónica Zuzarte; Subhasish Chatterjee; Ruth E Stark; Arturo Casadevall; Teresa Gonçalves
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

2.  Utility of molecular identification in opportunistic mycotic infections: a case of cutaneous Alternaria infectoria infection in a cardiac transplant recipient.

Authors:  G Lo Cascio; M Ligozzi; L Maccacaro; R Fontana
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

3.  Ulocladium atrum keratitis.

Authors:  P R Badenoch; C L Halliday; D H Ellis; K J Billing; R A D Mills
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

Review 4.  Echinocandins - structure, mechanism of action and use in antifungal therapy.

Authors:  Mateusz Szymański; Sandra Chmielewska; Urszula Czyżewska; Marta Malinowska; Adam Tylicki
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

5.  Alternaria chartarum sclerokeratouveitis: A new fungus cause.

Authors:  Luz Elena Concha Del Río; Carolina Ramirez-Dominguez; Virginia Vanzzini-Zago; Lourdes Arellanes-Garcia
Journal:  Taiwan J Ophthalmol       Date:  2020-04-27

6.  Clinical characteristics of alternaria keratitis.

Authors:  Ching-Hsi Hsiao; Lung-Kun Yeh; Hung-Chi Chen; Hsin-Chiung Lin; Phil Y F Chen; David H K Ma; Hsin-Yuan Tan
Journal:  J Ophthalmol       Date:  2014-03-20       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.